InNexus Biotechnology receives patent grants in Europe
InNexus Biotechnology Inc. announced in a press release that it has received patent grants in Germany, Spain, France, Great Britain and Italy further expanding patent protection of its DXL technology in Europe.
BioAlliance Pharma SA, the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, today announced the grant of its main patent on the Lauriad® technology in Europe.